PharmaLundensis AB

ISIN SE0027620469Filings at the FI

At a glance

Most recent filing on July 5, 2026 — a sale by Tord Staffan Håkan Skogvall on Jul 1, 2026.

We hold 2 visible filings, going back to June 4, 2026.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 2 shown

This page is free to read, and it stops after 2 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Tord Staffan Håkan Skogvall Chief executive officer
59,492 SEKOpen-market sale
TradedJul 1, 2026FiledJul 5, 2026
Tord Staffan Håkan Skogvall Chief executive officer
165,386 SEKOpen-market sale
TradedJun 4, 2026FiledJun 8, 2026